Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Muzeyyen Aslaner Ak"'
Autor:
Ibrahim Halil Acar, Muzeyyen Aslaner Ak, Gulsah Akyol, Taha Ulutan Kars, Yildiz Ipek, Ayse Uysal, Figen Atalay, Aysun Senturk Yikilmaz, Omer Ekinci, Idris Ince, Birgul Onec, Hakan Keski, Mufide Okay Ozgeyik, Sebnem Izmir Guner, Esra Terzi Demirsoy, Oktay Bilgir, Birol Guvenc
Publikováno v:
Medicina, Vol 60, Iss 10, p 1623 (2024)
Background and Objectives: Acute myeloid leukemia and myelodysplastic syndrome are both clonal hematologic malignancies that primarily affect older adults. Current treatments for AML/MDS are both limited in number and efficacy. This study aims to eva
Externí odkaz:
https://doaj.org/article/3bac2331ab0843e7ac42188b71925530
Autor:
İbrahim Halil Açar, Sebnem Izmir Güner, Muzeyyen Aslaner Ak, Mesut Gocer, Erman Ozturk, Figen Atalay, Gulden Sincan, Aysun Senturk Yikilmaz, Omer Ekinci, Idris Ince, Emine Gulturk, Nazli Demir, Ali Dogan, Yildiz Ipek, Birol Guvenc
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 14, Iss 1 (2022)
Objectives: Patients with hematologic malignancies have a high risk of coronavirus disease 2019 (COVID-19) mortality. This study aimed to investigate the impact of COVID-19 on mortality rates in patients with various hematologic malignancies and to d
Externí odkaz:
https://doaj.org/article/84dd9a8b2377465180f49123c3042ffc
Autor:
Ibrahim Halil, Acar, Sebnem Izmir, Guner, Muzeyyen Aslaner, Ak, Mesut, Gocer, Erman, Ozturk, Figen, Atalay, Gulden, Sincan, Aysun Senturk, Yikilmaz, Omer, Ekinci, Idris, Ince, Emine, Gulturk, Nazli, Demir, Ali, Dogan, Yildiz, Ipek, Birol, Guvenc
Publikováno v:
Mediterranean journal of hematology and infectious diseases. 14(1)
Patients with hematological malignancies have a high risk of mortality from coronavirus disease 2019 (COVID-19). This study aimed to investigate the impact of COVID-19 on mortality rates in patients with various hematological malignancies and to dete
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::feca705d41dd0808ff596b969dacb2a1
https://pubmed.ncbi.nlm.nih.gov/36425152
https://pubmed.ncbi.nlm.nih.gov/36425152
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 28(3)
Introduction Nilotinib is a second generation Tyrosine Kinase inhibitor (TKI) used in the treatment of Chronic Myeloid Leukemia (CML). The development of tyrosine kinase inhibitors has transformed chronic phase chronic myeloid leukemia from a disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::092e625204cf61669660de42e992e35f
https://pubmed.ncbi.nlm.nih.gov/35465793
https://pubmed.ncbi.nlm.nih.gov/35465793
Autor:
Ali Zahit Bolaman, Tugba Hacibekiroglu, Merve Gökçen Polat, Yasin Kalpakci, Sehmus Ertop, Muzeyyen Aslaner Ak, Mehmer Ali Ucar, Birol Guvenc, Hacer Kale, Ayfer Gedük, Birsen Sahip
Publikováno v:
Indian J Hematol Blood Transfus
This study aimed to evaluate the clinical efficacy of epoetin alfa and darbepoetin alfa in patients with myelodysplastic syndromes (MDS) in the real-life setting. A total of 204 patients with low-risk or intermediate-1-risk MDS who received epoetin a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f392f495a9f8a1da690576ec5ce24f62
https://europepmc.org/articles/PMC9001769/
https://europepmc.org/articles/PMC9001769/
Autor:
Atakan Tekinalp, Ayfer Gedük, Aydan Akdeniz, Esra Terzi Demirsoy, Vildan Gürsoy, Müzeyyen Aslaner Ak, Metin Bağcı, Sema Seçilmiş, Fatma Keklik Karadağ, Ayşe Oruç Uysal, Ali Doğan, Sinan Demircioğlu, Haşim Atakan Erol, Ceyda Aslan, Fahir Özkalemkaş, Şehmus Ertop, Mehmet Dağlı, Mehmet Sinan Dal, Güray Saydam, Mustafa Merter, Cihan Ural, Özcan Çeneli
Publikováno v:
Turkish Journal of Hematology, Vol 40, Iss 4, Pp 242-250 (2023)
Objective: This study aimed to evaluate patients with relapsed/ refractory multiple myeloma (RRMM) who underwent daratumumab (DARA) therapy. Materials and Methods: This multicenter retrospective study included 134 patients who underwent at least two
Externí odkaz:
https://doaj.org/article/4debcdb81b4a4484a3947f563fe04669
Publikováno v:
Journal of Cancer Research and Therapeutics. 18:1165
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aadb674c5f8a53f53d248b378f5421ae
https://doi.org/10.4103/jcrt.jcrt_156_22
https://doi.org/10.4103/jcrt.jcrt_156_22
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp 5- (2024)
Objective: Immune thrombocytopenia (ITP) is an acquired, autoimmune disease affecting 2 to 4 individuals per 100,000 annually. ITP is characterized by an isolated platelet count of 75% of adult patients respond to corticosteroids, only 20-30% remain
Externí odkaz:
https://doaj.org/article/f9aeeccea4b14bf09dc0155e84ad0c2b
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp 14-15 (2024)
Objective: Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy characterized by clonal expansion of myeloid blasts in peripheral blood, bone marrow, and/or other tissues. It is the most common type of acute leukemia in adults with
Externí odkaz:
https://doaj.org/article/6eaed50c213d47fc90131fa95d177f78
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp 17-18 (2024)
Objective: Diffuse large B-cell lymphoma (DLBCL) is the most common histological subtype of non-Hodgkin lymphoma (NHL). Extra nodal involvement of B-cell lymphoma is usually seen in the gastrointestinal system, followed by the skin. Skin involvement
Externí odkaz:
https://doaj.org/article/41049165150d49d587de92b7d5a61c92